Previous safe administrations of neuromuscular blocking agents do not exonerate from the risk of anaphylactic shock.
We describe a grade IV anaphylactic shock to atracurium. A 34-year-old woman was scheduled for her ninth abdominal surgery. Within the last 10 months, for previous abdominal procedures she had received atracurium, cisatracurium or suxamethonium. No adverse event was reported. In the present case, a cardiac arrest occurred within 1 min after atracurium injection. Anaphylaxis was immediately evoked and treatment started. The diagnosis of anaphylaxis to atracurium was confirmed by the allergological assessment. This case report highlights the fact that patients without any previous adverse events to neuromuscular blocking agents are never exempt from risk of anaphylactic shock, even with a designated low-risk agent of sensitization.
Cottenceau
V
V
Service d'anesthésie-réanimation-I, hôpital Pellegrin, centre hospitalo-universitaire de Bordeaux, université Victor Segalen-Bordeau-2, 33076 Bordeaux, France.
Dewachter
P
P
Nouette-Gaulain
K
K
Sztark
F
F
D000328:Adult; D000707:Anaphylaxis / Q000453:epidemiology*; D005260:Female; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use* / Q000633:toxicity*; D012307:Risk Factors; D012449:Safety; D016896:Treatment Outcome
D009466:Neuromuscular Blocking Agents